Stride, Inc.LRNNYSE
LOADING
|||

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
17 analysts·Moderate coverage
29%
Rating Distribution
Strong Buy
00%
Buy
529%
Hold
1059%
Sell
212%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 59% higher.

Bear Case
$94.00
+11%
Consensus
$134.67
+59%
Bull Case
$185.00
+119%
Price Range17 analysts
Low
Consensus
High
$94.00
$185.00
Current Target
Current Price
$84.60
Upside to Target
$50.07

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 28, 2026BMO Capital
Stride Inc. (LRN) PT Raised to $94 at BMO Capital
Target:$94.00
+7.7%from $87.26
Jan 28, 2026Canaccord Genuity
Canaccord Genuity Reiterates Buy Rating on Stride Inc. (LRN)
Target:$125.00
+44.5%from $86.52
Oct 29, 2025BMO Capital
BMO downgrades Stride on 'disappointing' fiscal 2026 outlook
Target:$108.00
-29.7%from $153.53
Aug 29, 2025Barrington
Stride price target raised to $185 from $170 at Barrington
Target:$185.00
+11.1%from $166.48
Apr 30, 2025Barrington
Stride price target raised to $170 from $150 at Barrington
Target:$170.00
+19.5%from $142.25
Oct 24, 2024BMO Capital
Stride Inc. (LRN) PT Raised to $88 at BMO Capital
Target:$88.00
-0.7%from $88.59
Oct 23, 2024Canaccord Genuity
Stride Inc. (LRN) PT Raised to $100 at Canaccord Genuity
Target:$100.00
+55.1%from $64.49
Aug 19, 2024Citigroup
Citi downgrades Stride to Neutral amid heightened uncertainty
Target:$90.00
+7.4%from $83.77
Aug 8, 2024BMO Capital
Stride Inc. (LRN) PT Raised to $82 at BMO Capital
Target:$82.00
+4.5%from $78.48
Apr 25, 2024BMO Capital
Stride Inc. (LRN) PT Raised to $73 at BMO Capital
Target:$73.00
+15.5%from $63.23
Apr 14, 2023Barrington
Stride's Favorable Longer-Term Outlook Convinces Analyst To See 30% Upside From Current Levels
Target:$50.00
+30.5%from $38.31
Aug 25, 2022Morgan Stanley
Stride upgraded to Overweight from Equal Weight at Morgan Stanley
Target:$45.00
+26.7%from $35.52
Apr 20, 2022Morgan Stanley
Stride Beats Q3 Expectations; Shares Rise 5.6%
Target:$39.00
-2.0%from $39.81